Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Histopathology. 2014 Oct 28;66(2):225–233. doi: 10.1111/his.12535

Figure 2.

Figure 2

Expression of islet 1, serotonin, CDX2 and CDH17 in non-sclerosing and sclerosing pancreatic neuroendocrine tumors (original magnification 200×). A-B: Immunohistochemical labeling of islet 1 in non-sclerosing tumor (A) and sclerosing tumor (B); C-D: Immunohistochemical labeling of serotonin in non-sclerosing tumor (C) and sclerosing tumor (D); E-F: Immunohistochemical labeling of CDX2 in non-sclerosing tumor (E) and sclerosing tumor (F); G-H: immunohistochemical labeling of CDH17 in non-sclerosing tumor (G) and sclerosing tumor (H).